Growth Metrics

Zepp Health (ZEPP) Common Equity (2016 - 2025)

Zepp Health has reported Common Equity over the past 11 years, most recently at $214.5 million for Q4 2025.

  • For Q4 2025, Common Equity fell 14.73% year-over-year to $214.5 million; the TTM value through Dec 2025 reached $214.5 million, down 14.73%, while the annual FY2025 figure was $214.5 million, 14.73% down from the prior year.
  • Common Equity for Q4 2025 was $214.5 million at Zepp Health, down from $251.6 million in the prior quarter.
  • Over five years, Common Equity peaked at $458.8 million in Q4 2021 and troughed at $214.5 million in Q4 2025.
  • A 5-year average of $329.7 million and a median of $347.8 million in 2023 define the central range for Common Equity.
  • Biggest five-year swings in Common Equity: increased 11.37% in 2021 and later fell 27.67% in 2024.
  • Year by year, Common Equity stood at $458.8 million in 2021, then fell by 18.1% to $375.8 million in 2022, then decreased by 7.43% to $347.8 million in 2023, then fell by 27.67% to $251.6 million in 2024, then decreased by 14.73% to $214.5 million in 2025.
  • Business Quant data shows Common Equity for ZEPP at $214.5 million in Q4 2025, $251.6 million in Q4 2024, and $347.8 million in Q4 2023.